The ACME Laboratories Statistics

Total Valuation

DSE:ACMELAB has a market cap or net worth of BDT 16.59 billion. The enterprise value is 37.01 billion.

Market Cap	16.59B
Enterprise Value	37.01B

Important Dates

The next estimated earnings date is Sunday, April 26, 2026.

Earnings Date	Apr 26, 2026
Ex-Dividend Date	Nov 19, 2025

Share Statistics

DSE:ACMELAB has 211.60 million shares outstanding.

Current Share Class	211.60M
Shares Outstanding	211.60M
Shares Change (YoY)	n/a
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	38.45%
Owned by Institutions (%)	7.51%
Float	130.25M

Valuation Ratios

The trailing PE ratio is 6.47.

PE Ratio	6.47
Forward PE	n/a
PS Ratio	0.43
PB Ratio	0.61
P/TBV Ratio	0.61
P/FCF Ratio	9.83
P/OCF Ratio	3.85
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.14, with an EV/FCF ratio of 21.92.

EV / Earnings	14.44
EV / Sales	0.95
EV / EBITDA	4.14
EV / EBIT	5.42
EV / FCF	21.92

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.90.

Current Ratio	1.17
Quick Ratio	0.35
Debt / Equity	0.90
Debt / EBITDA	2.75
Debt / FCF	14.59
Interest Coverage	2.09

Financial Efficiency

Return on equity (ROE) is 9.72% and return on invested capital (ROIC) is 10.04%.

Return on Equity (ROE)	9.72%
Return on Assets (ROA)	7.22%
Return on Invested Capital (ROIC)	10.04%
Return on Capital Employed (ROCE)	18.38%
Weighted Average Cost of Capital (WACC)	7.34%
Revenue Per Employee	4.31M
Profits Per Employee	283,982
Employee Count	9,025
Asset Turnover	0.66
Inventory Turnover	1.81

Taxes

In the past 12 months, DSE:ACMELAB has paid 1.05 billion in taxes.

Income Tax	1.05B
Effective Tax Rate	29.01%

Stock Price Statistics

The stock price has increased by +4.67% in the last 52 weeks. The beta is 0.01, so DSE:ACMELAB's price volatility has been lower than the market average.

Beta (5Y)	0.01
52-Week Price Change	+4.67%
50-Day Moving Average	74.42
200-Day Moving Average	75.21
Relative Strength Index (RSI)	57.83
Average Volume (20 Days)	738,189

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:ACMELAB had revenue of BDT 38.86 billion and earned 2.56 billion in profits. Earnings per share was 12.11.

Revenue	38.86B
Gross Profit	16.32B
Operating Income	6.82B
Pretax Income	3.61B
Net Income	2.56B
EBITDA	8.91B
EBIT	6.82B
Earnings Per Share (EPS)	12.11

Full Income Statement

Balance Sheet

The company has 4.21 billion in cash and 24.63 billion in debt, giving a net cash position of -20.42 billion or -96.49 per share.

Cash & Cash Equivalents	4.21B
Total Debt	24.63B
Net Cash	-20.42B
Net Cash Per Share	-96.49
Equity (Book Value)	27.29B
Book Value Per Share	128.97
Working Capital	3.97B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 4.31 billion and capital expenditures -2.62 billion, giving a free cash flow of 1.69 billion.

Operating Cash Flow	4.31B
Capital Expenditures	-2.62B
Free Cash Flow	1.69B
FCF Per Share	7.98

Full Cash Flow Statement

Margins

Gross margin is 42.01%, with operating and profit margins of 17.56% and 6.60%.

Gross Margin	42.01%
Operating Margin	17.56%
Pretax Margin	9.29%
Profit Margin	6.60%
EBITDA Margin	22.93%
EBIT Margin	17.56%
FCF Margin	4.34%

Dividends & Yields

This stock pays an annual dividend of 3.50, which amounts to a dividend yield of 4.40%.

Dividend Per Share	3.50
Dividend Yield	4.40%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	28.90%
Buyback Yield	n/a
Shareholder Yield	4.40%
Earnings Yield	15.45%
FCF Yield	10.18%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

DSE:ACMELAB has an Altman Z-Score of 1.74 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.74
Piotroski F-Score	7